ResearcherUniversity of ToyamaNo recent work listed
Takahiko Nakajima
Matched on ORCID iD 0000-0002-2603-9216; OpenAlex author ID A5021776984. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 3
2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper
Papers 3
- Interleukin-32 regulates downstream molecules and promotes the invasion of pancreatic cancer cells. Last author DOI 10.3892/ol.2021.13132↗
- Establishment of highly invasive pancreatic cancer cell lines and the expression of IL-32. Last author DOI 10.3892/ol.2020.11825↗
- Endoglin (CD105) and SMAD4 regulate spheroid formation and the suppression of the invasive ability of human pancreatic cancer cells. Co-author DOI 10.3892/ijo.2018.4262↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Johji Imura · 3 shared papers, 2018–2022 · strength 0.35
- Paper Interleukin-32 regulates downstream molecules and promotes the invasion of pancreatic cancer cells. DOI 10.3892/ol.2021.13132↗
- Paper Establishment of highly invasive pancreatic cancer cell lines and the expression of IL-32. DOI 10.3892/ol.2020.11825↗
- Paper Endoglin (CD105) and SMAD4 regulate spheroid formation and the suppression of the invasive ability of human pancreatic … DOI 10.3892/ijo.2018.4262↗
- Kohji Takagi · 2 shared papers, 2020–2022 · strength 0.26
- Eri Kokaji · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.